Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

Ambu Misses Revenue Growth, EBIT Margin Guidance for the Year; Endoscopes Sold Exceeds Outlook

5/10 17:38


  • (PLX AI) – Ambu 2020/21 Organic revenue growth of approx. 16% where guidance was approx. 17%.
  • • Ambu 2020/21 EBIT margin in the range of 8.5-9.0% where guidance was approx. 10%.
  • • Ambu 2020/21 total number of endoscopes sold at approx. 1.525 million units, where guidance was above 1.4 million units
  • • Q4 revenue DKK 1,027 million vs. estimate DKK 1,039 million
  • • Q4 organic growth 18%
  • • Ambu says further impact from shipment delays on our Core business (Anaesthesia and Patient Monitoring & Diagnostics) caused by the congestion of the global container freight market
  • • Visualization business has not been impacted by the shipment delays as we have been relying on airfreight to support demand for Visualization products throughout the year
  • • Full year organic growth of the Visualization business is expected to end at approx. 31%